BMS’s Iberdomide Scores First Major Phase III Win

 
• By Alaric DeArment
  
Bristol Myers Squibb at ASH 2024 (Alaric DeArment/Scrip)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas